NCT01320436View on ClinicalTrials.gov

Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions

Ulcerative Colitis

Interventions

DIETARY_SUPPLEMENT

Curcumin

3 capsules (820 mg containig 500 mg curcumin each) twice daily.

DRUG

5-aminosalicylic acid

The dosage of 5ASA medication will be the maximum dosage given in this group of patients according to clinical guidelines (4gr' per os + topical 1gr mesalamine

Trial Locations (1)

Unknown

Sheba Medical Center, Ramat Gan

All Listed Sponsors

lead

Sheba Medical Center

OTHER_GOV

NCT01320436 - Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis | Biotech Hunter | Biotech Hunter